Regulatory bodies like the FDA use systems such as the Adverse Event Reporting System (AERS) to monitor and evaluate drug safety after a product hits the market. Health professionals and consumers can report adverse events or product quality problems, which are then analyzed to identify trends and concerns. Epidemiologists play a key role in the assessment and interpretation of this data.
